2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
151
Gastrointestinal
73
Genitourinary
44
Other hematologic neoplasm
37
Thoracic
34
Lymphoid
33
Other
28
Tumor-Agnostic
18
Gynecologic
18
Head & Neck
12
Plasma cell
11
CNS
10
Endocrine
5
Dermatologic
5
Sarcoma
2
Other solid neoplasm
2
Myeloid
2
Other neoplasm
1
Classical hematology
1
Conditions
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Cytopenia
1
Interventions
Cyclophosphamide
261
fludarabine phosphate
233
Azacitidine
182
fludarabine
181
Busulfan
176
Cytarabine
155
Imatinib Mesylate
152
Mycophenolic Acid
148
Tacrolimus
146
Whole-Body Irradiation
142
Peripheral Blood Stem Cell Transplantation
140
Cyclosporine
110
Antilymphocyte Serum
108
Melphalan
107
Methotrexate
105
Filgrastim
101
Decitabine
98
nilotinib
94
venetoclax
79
ruxolitinib
79
Dasatinib
68
Granulocyte Colony-Stimulating Factor
66
Stem Cell Transplantation
63
Thiotepa
60
Radiotherapy
60
thymoglobulin
52
Specimen Handling
49
Etoposide
49
Clofarabine
46
Cord Blood Stem Cell Transplantation
45
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Exercise
×
Myeloid
×
Clear all
NCT07384039
2026-02-05
MPN-Exercise
Hannover Medical School
Phase NA
Not yet recruiting
80 enrolled
NCT06773871
2025-08-19
HemEx
Rigshospitalet, Denmark
Phase NA
Recruiting
36 enrolled